A Randomised Controlled Pilot Trial: Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy
| Registry | NCT04470102, acronym PRIZMA-pilot |
|---|---|
| Status | Unknown |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 40 (Estimated) |
| Sponsor | Meshalkin Research Institute of Pathology of Circulation (Network) |
| Conditions | Hypertrophic Obstructive Cardiomyopathy |
| Interventions | mitral valve repair by edge-to-edge technique, Septal myectomy (Procedure) |
| Dates | start 2020-03-12, primary completion 2021-01-31 (estimated), completion 2022-01-31 (estimated), first posted 2020-07-14, last updated 2020-07-21 |
| Locations | 1 site in Russia |
Related Papers Related Patents Related Grants Related Experts
All trials for Hypertrophic Obstructive Cardiomyopathy All trials of mitral valve repair by edge-to-edge technique All trials of Septal myectomy
Objective of the study: to evaluate whether edge-to-edge technique improves clinical and hemodynamic results in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy.
A randomised controlled pilot trial to evaluate whether edge-to-edge technique improves clinical and hemodynamic results in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy. Patients with proven hypertrophic cardiomyopathy and resting left ventricle outflow tract obstruction underwent septal myectomy. If patients were suitable for both surgical techniques, they were randomized to septal myectomy + edge-to-edge mitral valve repair or isolated septal myectomy. All surgeons were experienced at least 50 related procedures.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| isolated septal myectomy | Other | Procedure: Septal myectomy | Isolated extended septal myectomy |
| Septal myectomy+ "edge-to-edge" | Active comparator | Procedure: mitral valve repair by edge-to-edge technique | advanced septal myectomy in combination with mitral valve repair using the edge-to-edge technique |
Sex: All, ages: 18 Years to 70 Years
Inclusion Criteria: * Provide written informed consent (either from the patient or a substitute decision-maker) * Indications for surgical treatment (septal myectomy) of hypertrophic cardiomyopathy Exclusion Criteria: * indications for mitral valve replacement * Patient failure at any stage of the study
| Facility | City | Country | Status |
|---|---|---|---|
| "E.Meshalkin National medical research center" of the Ministry of Health of the Russian Federation | Novosibirsk | Russia | Recruiting |